363 related articles for article (PubMed ID: 18414782)
21. FancJ (Brip1) loss-of-function allele results in spermatogonial cell depletion during embryogenesis and altered processing of crossover sites during meiotic prophase I in mice.
Sun X; Brieño-Enríquez MA; Cornelius A; Modzelewski AJ; Maley TT; Campbell-Peterson KM; Holloway JK; Cohen PE
Chromosoma; 2016 Jun; 125(2):237-52. PubMed ID: 26490168
[TBL] [Abstract][Full Text] [Related]
22. Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair.
Cantor SB; Xie J
Environ Mol Mutagen; 2010 Jul; 51(6):500-7. PubMed ID: 20658644
[TBL] [Abstract][Full Text] [Related]
23. Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.
Shen X; Do H; Li Y; Chung WH; Tomasz M; de Winter JP; Xia B; Elledge SJ; Wang W; Li L
Mol Cell; 2009 Sep; 35(5):716-23. PubMed ID: 19748364
[TBL] [Abstract][Full Text] [Related]
24. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
Lewis AG; Flanagan J; Marsh A; Pupo GM; Mann G; Spurdle AB; Lindeman GJ; Visvader JE; Brown MA; Chenevix-Trench G;
Breast Cancer Res; 2005; 7(6):R1005-16. PubMed ID: 16280053
[TBL] [Abstract][Full Text] [Related]
25. Retesting of women who are negative for a
Lerner-Ellis J; Sopik V; Wong A; Lázaro C; Narod SA; Charames GS
J Med Genet; 2020 Jun; 57(6):380-384. PubMed ID: 31784482
[TBL] [Abstract][Full Text] [Related]
26. No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22.
Luo L; Lei H; Du Q; von Wachenfeldt A; Kockum I; Luthman H; Vorechovsky I; Lindblom A
Int J Cancer; 2002 Apr; 98(4):638-9. PubMed ID: 11920628
[No Abstract] [Full Text] [Related]
27. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.
Kote-Jarai Z; Jugurnauth S; Mulholland S; Leongamornlert DA; Guy M; Edwards S; Tymrakiewitcz M; O'Brien L; Hall A; Wilkinson R; Al Olama AA; Morrison J; Muir K; Neal D; Donovan J; Hamdy F; Easton DF; Eeles R; ;
Br J Cancer; 2009 Jan; 100(2):426-30. PubMed ID: 19127258
[TBL] [Abstract][Full Text] [Related]
28. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
[TBL] [Abstract][Full Text] [Related]
29. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
[TBL] [Abstract][Full Text] [Related]
30. DOG-1 is the Caenorhabditis elegans BRIP1/FANCJ homologue and functions in interstrand cross-link repair.
Youds JL; Barber LJ; Ward JD; Collis SJ; O'Neil NJ; Boulton SJ; Rose AM
Mol Cell Biol; 2008 Mar; 28(5):1470-9. PubMed ID: 18086896
[TBL] [Abstract][Full Text] [Related]
31. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
32. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
[TBL] [Abstract][Full Text] [Related]
33. Activation of BRCA1/BRCA2-associated helicase BACH1 is required for timely progression through S phase.
Kumaraswamy E; Shiekhattar R
Mol Cell Biol; 2007 Oct; 27(19):6733-41. PubMed ID: 17664283
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of FANCJ helicase.
Guo M; Vidhyasagar V; Talwar T; Kariem A; Wu Y
Methods; 2016 Oct; 108():118-29. PubMed ID: 27107905
[TBL] [Abstract][Full Text] [Related]
35. Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer.
Park JS; Lee ST; Nam EJ; Han JW; Lee JY; Kim J; Kim TI; Park HS
BMC Cancer; 2018 Jan; 18(1):83. PubMed ID: 29338689
[TBL] [Abstract][Full Text] [Related]
36. Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey.
Cecener G; Guney Eskiler G; Egeli U; Tunca B; Alemdar A; Gokgoz S; Tasdelen I
Mol Biol Rep; 2016 Nov; 43(11):1273-1284. PubMed ID: 27573125
[TBL] [Abstract][Full Text] [Related]
37. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY
Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968
[TBL] [Abstract][Full Text] [Related]
38. BRIP1, a potential candidate gene in development of non-BRCA1/2 breast cancer.
Ouhtit A; Gupta I; Shaikh Z
Front Biosci (Elite Ed); 2016 Jan; 8(2):289-98. PubMed ID: 26709662
[TBL] [Abstract][Full Text] [Related]
39. Assessing the link between BACH1 and BRCA1 in the FA pathway.
Cantor SB; Andreassen PR
Cell Cycle; 2006 Jan; 5(2):164-7. PubMed ID: 16357529
[TBL] [Abstract][Full Text] [Related]
40. FANCJ helicase operates in the Fanconi Anemia DNA repair pathway and the response to replicational stress.
Wu Y; Brosh RM
Curr Mol Med; 2009 May; 9(4):470-82. PubMed ID: 19519404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]